Published in Genes Chromosomes Cancer on March 01, 1999
The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A (2005) 3.49
Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet (2007) 2.53
How does the Schwann cell lineage form tumors in NF1? Glia (2008) 1.63
Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet (2007) 1.33
Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts. J Biol Chem (2000) 1.32
Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Am J Pathol (2001) 1.30
Control of Drosophila perineurial glial growth by interacting neurotransmitter-mediated signaling pathways. Proc Natl Acad Sci U S A (2001) 1.09
Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms. Acta Neuropathol (2011) 1.04
Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH. Hum Mutat (2011) 1.01
Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells. Oncogene (2004) 0.98
Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis. Mol Cell Biol (2003) 0.97
It takes two to tango: mast cell and Schwann cell interactions in neurofibromas. J Clin Invest (2003) 0.95
Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression. Annu Rev Pathol (2011) 0.91
Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Am J Hum Genet (2000) 0.89
Mast cells can contribute to axon-glial dissociation and fibrosis in peripheral nerve. Neuron Glia Biol (2007) 0.88
Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients. Eur J Hum Genet (2010) 0.85
Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures. J Clin Neurol (2015) 0.81
Immune system evasion by peripheral nerve sheath tumor. Neurosci Lett (2006) 0.81
A patient with neurofibromatosis type 1 and Charcot-Marie-Tooth disease type 1B. Muscle Nerve (2010) 0.77
Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis. Acta Neuropathol (2014) 0.77
Immortalization of human normal and NF1 neurofibroma Schwann cells. Lab Invest (2016) 0.76
Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care. Ophthalmology (2016) 0.75
Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses. J Virol (1990) 3.77
Diagnostic criteria for schwannomatosis. Neurology (2005) 3.41
Nucleotide sequence of the envelope gene of Friend murine leukemia virus. J Virol (1983) 3.41
Molecular analysis of the envelope gene and long terminal repeat of Friend mink cell focus-inducing virus: implications for the functions of these sequences. J Virol (1984) 3.09
Nucleotide sequence at the 5' terminus of the avian sarcoma virus genome. Proc Natl Acad Sci U S A (1977) 2.66
Nucleotide sequence that binds primer for DNA synthesis to the avian sarcoma virus genome. J Virol (1976) 2.28
Characterization of DNA complementary to nucleotide sequences at the 5'-terminus of the avian sarcoma virus genome. Virology (1977) 2.16
Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety. Neuroradiology (1999) 1.99
Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure. Proc Natl Acad Sci U S A (1987) 1.44
A new Puumala hantavirus subtype in rodents associated with an outbreak of Nephropathia epidemica in South-East Germany in 2004. Epidemiol Infect (2006) 1.43
[Cyclosporin A in therapy of chronic uveitis]. Ophthalmologe (1992) 1.40
Universality of small scale turbulence. Phys Rev Lett (2002) 1.39
Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. J Neuropathol Exp Neurol (2001) 1.26
Differences between genomes of two strains of mouse mammary tumor virus as shown by partial RNA sequence analysis. Virology (1976) 1.25
Effect of viral RNase H on the avian sarcoma viral genome during early transcription in vitro. J Virol (1979) 1.16
Mosaicism in sporadic neurofibromatosis 2 patients. Hum Mol Genet (1998) 1.14
Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients. Neurobiol Dis (1998) 1.12
Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene. Anticancer Res (2005) 1.08
Estimation of the equivalent pore dimensions in the rabbit placenta. Life Sci (1969) 1.08
Growth type of plexiform neurofibromas in NF1 determined on magnetic resonance images. Anticancer Res (2003) 1.06
RNA-RNA hybridization in aqueous solutions containing formamide. Anal Biochem (1972) 1.05
Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes. Hum Genet (1996) 1.05
Phenotypic variability associated with 14 splice-site mutations in the NF2 gene. Am J Med Genet (1998) 1.00
A theoretical model of phase transitions in the human brain. Biol Cybern (1994) 0.99
Elongation of DNA complementary to the 5' end of the avian sarcoma virus genome by the virion-associated RNA-dependent DNA polymerase. J Virol (1979) 0.98
The staphylocoagulase family of zymogen activator and adhesion proteins. Cell Mol Life Sci (2004) 0.98
Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children. Anticancer Res (2007) 0.97
High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1. Osteoporos Int (2009) 0.95
Sequence analysis of Gardner-Arnstein feline leukaemia virus envelope gene reveals common structural properties of mammalian retroviral envelope genes. EMBO J (1983) 0.95
Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours. Eur J Cancer (2004) 0.94
Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis? Br J Dermatol (2003) 0.92
Noise-covered drift bifurcation of dissipative solitons in a planar gas-discharge system. Phys Rev E Stat Nonlin Soft Matter Phys (2003) 0.92
Allelic losses in neurofibromatosis 2-associated meningiomas. J Neuropathol Exp Neurol (2000) 0.90
The diagnosis and management of neurofibromatosis 2 in childhood. Semin Pediatr Neurol (1998) 0.89
[Absorption of microcrystalline cellulose]. Naturwissenschaften (1974) 0.89
The parental origin of new mutations in neurofibromatosis 2. Neurogenetics (2000) 0.88
Extracting strong measurement noise from stochastic time series: applications to empirical data. Phys Rev E Stat Nonlin Soft Matter Phys (2010) 0.88
Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients. Anticancer Res (2003) 0.87
Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy. J Neurol (2012) 0.86
Characterization of messenger RNA specific for carcinoembryonic antigen. Ann N Y Acad Sci (1983) 0.86
High frequency of nonsense mutations in the NF2 gene caused by C to T transitions in five CGA codons. Hum Mol Genet (1995) 0.86
Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Cancer Genet Cytogenet (1999) 0.85
Comment on "Indispensable finite time corrections for Fokker-Planck equations from time series data". Phys Rev Lett (2002) 0.83
Changes of extracellular Na+, K+, Ca2+ and H+ of the ischemic myocardium in pigs. Basic Res Cardiol (1981) 0.83
Cochlear implantation after acoustic tumour resection in neurofibromatosis type 2: impact of intra- and postoperative neural response telemetry monitoring. ORL J Otorhinolaryngol Relat Spec (2003) 0.82
Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine. J Nucl Med (1986) 0.82
A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2. Hum Genet (1996) 0.82
Diffuse colonic varices: an uncommon cause of intestinal bleeding. Am J Gastroenterol (1986) 0.82
Incorporation of beta-selenolo[3,2-b]pyrrolyl-alanine into proteins for phase determination in protein X-ray crystallography. J Mol Biol (2001) 0.82
Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors. J Invest Dermatol (2000) 0.81
Stochastic order parameter equation of isometric force production revealed by drift-diffusion estimates. Phys Rev E Stat Nonlin Soft Matter Phys (2006) 0.80
Role of epinephrine-induced hypokalemia in the regulation of renin and aldosterone in humans. J Lab Clin Med (1996) 0.80
Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2). Genet Epidemiol (2002) 0.79
Use of superoxide dismutase (SOD) in patients with temporomandibular joint dysfunction--a preliminary study. Int J Oral Maxillofac Surg (1994) 0.79
Abstracts of the 6th FECS Conference 1998 Lectures. Environ Sci Pollut Res Int (1998) 0.79
Health risks of energy systems. Risk Anal (1998) 0.78
Different methods to estimate the Einstein-Markov coherence length in turbulence. Phys Rev E Stat Nonlin Soft Matter Phys (2011) 0.78
[The Eppendorf Pruritus Questionnaire]. Hautarzt (1997) 0.78
Effect of actinomycin D on nucleic acid hybridization: the cause of erroneous DNA elongation during DNA synthesis of RNA tumor viruses in vitro. Biochim Biophys Acta (1980) 0.78
Modeling of nonlinear Lévy processes by data analysis. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 0.77
Joint probability distributions for a class of non-Markovian processes. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 0.77
Germ-line NF2 mutations and disease severity in neurofibromatosis type 2 patients with retinal abnormalities. Am J Hum Genet (1999) 0.77
Thymic nurse cells: intraepithelial thymocyte sojourn and its possible relevance for the pathogenesis of AKR lymphomas. Haematol Blood Transfus (1981) 0.77
Physics of brain dynamics: Fokker-Planck analysis reveals changes in EEG delta and theta activity during anaesthesia. New J Phys (2009) 0.77
A 163-bp deletion in the neurofibromatosis 2 (NF2) gene associated with variant phenotypes [corrected]. Hum Genet (1995) 0.77
[Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis]. Klin Monbl Augenheilkd (1999) 0.77
Detection of fixed points in spatiotemporal signals by a clustering method. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (2000) 0.77
Substance P and calcitonin gene-related peptide in the chicken skin: distribution and cardiovascular effects. Neuropeptides (1996) 0.77
Langevin description of superdiffusive Lévy processes. Phys Rev E Stat Nonlin Soft Matter Phys (2012) 0.76
Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations. Neurology (1996) 0.76
Continuous-time random walks: simulation of continuous trajectories. Phys Rev E Stat Nonlin Soft Matter Phys (2007) 0.76
Statistical analysis of global wind dynamics in vigorous Rayleigh-Bénard convection. Phys Rev E Stat Nonlin Soft Matter Phys (2011) 0.75
[Stimulant drugs in neurofibromatosis type 1 and attention deficit disorder]. Nervenarzt (2002) 0.75
Voltage-dependent membrane currents of cultured human neurofibromatosis type 2 Schwann cells. Glia (1998) 0.75
[A transit thrombus in the patent foramen ovale with pulmonary and paradoxical embolization]. Dtsch Med Wochenschr (1993) 0.75
[Studies of 5-nitrofurfural acetals. 3. Effect of 5-nitrofurfural-diethyl acetal in liver fluke implantation test according to Lienert]. Arch Exp Veterinarmed (1968) 0.75
[Psychopharmacology in general practice]. Med Welt (1965) 0.75
[Outpatient treatment of intestinal diseases with Mexaform S]. Landarzt (1965) 0.75
The effects of some bacterial toxins on placental transport in the rabbit. Toxicon (1972) 0.75
[On the treatment of bronchospastic ventilation disorders and respiratory insufficiency]. Med Monatsschr (1965) 0.75
[Clinical interpretation of retinal circulatory measurements. III. Blood flow velocity and vessel diameter in normal persons and in patients with venous occlusive diseases]. Ophthalmologica (1986) 0.75
The time-distance diagram: a new method to analyze ureteral peristalsis by cineradiography. Invest Urol (1980) 0.75
[Psychological adaptation to an implanted cardiac pacemaker. With special reference to adjustment and defense mechanisms]. MMW Munch Med Wochenschr (1983) 0.75
[Ambulant treatment of inflammatory and ulcerous diseases of the stomach and duodenum with a complex stomach preparation]. Med Welt (1965) 0.75
Impact of oral surgical practice and procedures on the administration of health care insurance. J Oral Surg (1966) 0.75
[Drug influence on screening tests for inborn errors of metabolism]. Monatsschr Kinderheilkd (1973) 0.75
[Clinical interpretation of retinal circulatory measurements. II. Blood flow]. Ophthalmologica (1986) 0.75
[Experience with a barbiturate-free hypnotic and sedative in general practice]. Med Welt (1966) 0.75
[Treatment of disorders of the autonomic nervous system with the daytime sedative Omnisedan]. Landarzt (1965) 0.75
[Peroral therapy of the varicose symptom complex with Essaven]. Med Monatsschr (1966) 0.75
[Practical experiences with the vein tonic Marron in the treatment of venous circulatory disorders]. Z Allgemeinmed (1969) 0.75
Brain uptake of 3H noradrenaline in normal and Shigella dysenteriae exotoxin treated mice. Experientia (1969) 0.75
Exact relation between Eulerian and Lagrangian velocity increment statistics. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 0.75
[Exocrine pancreas function test with Se75 labeled selenomethionine and the Lundh test]. Rev Roum Med Intern (1974) 0.75
Measurements of retinal microcirculation in retinal vessel occlusion before and after treatment. Graefes Arch Clin Exp Ophthalmol (1986) 0.75
[Experience and behavior parameters of chronically ill children--as shown in progressive muscular dystrophy]. Kinderarztl Prax (1983) 0.75
Critical assessment of the xenon washout technic for measurement of placental blood flow. Gynecol Invest (1973) 0.75
[On a safe percutaneous and oral treatment of degenerative joint diseases in general practice]. Landarzt (1965) 0.75